Disorders of Kidney Formation

Comprehensive Pediatric Nephrology

Volumn , Issue , 2008, Pages 131-141

  Rosenblum, Norman D ^a   Salomon, Remi ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882878256     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-04883-5.50013-1     Document Type: Chapter

References (94)

1. Seikaly MG, Ho PL, Emmett L, Fine RN, Tejani A Chronic renal insufficiency in children: the 2001 Annual Report of the NAPRTCS. Pediatr Nephrol 2003, 18:796-804.
2. Wiesel A, Queisser-Luft A, Clementi M, Bianca S, Stoll C Prenatal detection of congenital renal malformations by fetal ultrasonographic examination: an analysis of 709, 030 births in 12 European countries. Eur J Med Genet 2005, 48:131-144.
3. Piscione TD, Rosenblum N The malformed kidney: disruption of glomerular and tubular development. Clin Genet 1999, 56:343-358.
4. Queisser-Luft A, Stolz G, Wiesel A, Schlaefer K, Spranger J Malformations in newborn: results based on 30, 940 infants and fetuses from the Mainz congenital birth defect monitoring system (1990-1998). Arch Gynecol Obstet 2002, 266:163-167.
5. Limwongse C, Cassidy SB Syndromes and malformations of the urinary tract. Pediatric Nephrology 2004, Williams & Wilkins, Philadelphia. E.D. Avner, W.E. Harmon, P. Naudet (Eds.).
6. Winyard P, Chitty L Dysplastic and polycystic kidneys: diagnosis, associations and management. Prenat Diagn 2001, 21:924-935.
7. Harris J, Robert E, Kallen B Epidemiologic characteristics of kidney malformations. Eur J Epidemiol 2000, 16:985-992.
8. Roodhooft AM, Jason MD, Birnholz JC, Holmes LB Familial nature of congenital absence and severe dysgenesis of both kidneys. N Engl J Med 1984, 310:1341-1344.
9. Guarino N, et al. The incidence of associated urological abnormalities in children with renal ectopia. J Urol 2004, 172:1757-1759.
10. Weizer AZ, et al. Determining the incidence of horseshoe kidney from radiographic data at a single institution. J Urol 2003, 170:1722-1726.
11. Hu MC, Rosenblum ND Genetic regulation of branching morphogenesis: lessons learned from loss-of-function phenotypes. Pediatr Res 2003, 54:433-438.
12. Kang S, Graham JM, Olney AH, Biesecker LG GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome. Nat Genet 1997, 15:266-268.
13. Bose J, Grotewold L, Ruther U Pallister-Hall syndrome phenotype in mice mutant for Gli3. Hum Mol Genet 2002, 11:1129-1135.
14. Hu MC, et al. GLI3-dependent transcriptional repression of Gli1, Gli2 and kidney patterning genes disrupts renal morphogenesis. Development 2006, 133:569-578.
15. Abdelhak S, et al. A human homologue of the Drosophila eyes absent gene underlies Branchio-Oto-Renal (BOR) syndrome and identifies a novel gene family. Nature Gen 1997, 15:157-164.
16. Xu PX, et al. Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia. Nature Genet 1999, 23:113-117.
17. Ruf RG, et al. SIX1 mutations cause branchio-oto-renal syndrome by disruption of EYA1-SIX1-DNA complexes. Proc Natl Acad Sci USA 2004, 101:8090-8095.
18. Xu PX, et al. Six1 is required for the early organogenesis of mammalian kidney. Development 2003, 130:3085-3094.
19. Kohlhase J, Wischermann A, Reichenbach H, Froster U, Engel W Mutations in the SALL1 putative transcription factor gene cause Townes-Brocks syndrome. Nature Genet 1998, 18:81-83.
20. Weber S, et al. Prevalence of mutations in renal developmental genes in children with renal hypodysplasia: results of the ESCAPE study. J Am Soc Nephrol 2006, 17:2864-2870.
21. Nishinakamura R, et al. Murine homolog of SALL1 is essential for ureteric bud invasion in kidney development. Development 2001, 128:3105-3115.
22. Schwarz RD, Stephens FD, Cussen LJ The pathogenesis of renal dyplasia III. Complete and incomplete urinary obstruction. Invest Urol 1981, 19:101-103.
23. Kume T, Deng K, Hogan BLM Murine forkhead/winged helix genes Foxc1 (Mf1) and Foxc2 (Mfh1) are required for the early organogenesis of the kidney and urinary tract. Development 2000, 127:1387-1395.
24. Dziarmaga A, Eccles M, Goodyer P Suppression of ureteric bud apoptosis rescues nephron endowment and adult renal function in Pax2 mutant mice. J Am Soc Nephrol 2006, 17:1568-1575.
25. Mendelsohn C, Batourina E, Fung S, Gilbert T, Dodd J Stromal cells mediate retinoid-dependent functions essential for renal development. Development 1999, 126:1139-1148.
26. Batourina E, et al. Vitamin A controls epithelial/mesenchymal interactions through Ret expression. Nature Genet 2001, 27:74-78.
27. Leliévre-Pégorier M, et al. Mild vitamin A deficiency leads to inborn nephron deficit in the rat. Kidney Int 1998, 54:1455-1462.
28. Nyengaard JR, Bendtsen TF Glomerular number and size in relation to age, kidney weight, and body surface in normal man. Anat Rec 1992, 232:194-201.
29. Fraser FC, Ling D, Clogg D, Nogrady B Genetic aspects of the BOR syndrome-branchial fistulas, ear pits, hearing loss, and renal anomalies. Am J Med Genet 1978, 2:241-252.
30. Melnick M, Bixler D, Silk K, Yune H, Nance WE Autosomal dominant branchiootorenal dysplasia. Birth Defects Orig Artic Ser 1975, 11:121-128.
31. Chen A, et al. Phenotypic manifestations of branchio-oto-renal syndrome. Am J Med Genet 1995, 58:365-370.
32. Chang EH, et al. Branchio-oto-renal syndrome: the mutation spectrum in EYA1 and its phenotypic consequences. Hum Mutat 2004, 23:582-589.
33. Fraser FC, Sproule JR, Halal F Frequency of the branchio-oto-renal (BOR) syndrome in children with profound hearing loss. Am J Med Genet 1980, 7:341-349.
34. Kumar S, et al. Autosomal dominant branchio-oto-renal syndrome-localization of a disease gene to chromosome 8q by linkage in a Dutch family. Hum Mol Genet 1992, 1:491-495.
35. Sajithlal G, Zou D, Silvius D, Xu PX Eya1 acts as a critical regulator for specifying the metanephric mesenchyme. Dev Biol 2005, 284:323-336.
36. Vervoort VS, et al. Genomic rearrangements of EYA1 account for a large fraction of families with BOR syndrome. Eur J Hum Genet 2002, 10:757-766.
37. Weaver RG, et al. Optic nerve coloboma associated with renal disease. Am J Med Genet 1988, 29:597-605.
38. Fletcher J, et al. Multicystic dysplastic kidney and variable phenotype in a family with a novel deletion mutation of PAX2, J. Am Soc Nephrol 2005, 16:2754-2761.
39. Salomon R, et al. PAX2 mutations in oligomeganephronia. Kidney Int 2001, 59:457-462.
40. Dureau P, et al. Renal coloboma syndrome. Ophthalmology 2001, 108:1912-1916.
41. Parsa CF, et al. Redefining papillorenal syndrome: an underdiagnosed cause of ocular and renal morbidity. Ophthalmology 2001, 108:738-749.
42. Schimmenti LA, et al. Further delineation of renal-coloboma syndrome in patients with extreme variability of phenotype and identical PAX2 mutations. Am J Hum Genet 1997, 60:869-878.
43. Eccles MR, Schimmenti LA Renal-coloboma syndrome: a multisystem developmental disorder caused by PAX2 mutations. Clin Genet 1999, 56:1-9.
44. Sanyanusin P, et al. Mutation of the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux. Nature Genet 1995, 9:358-363.
45. Coffinier C, Thepot D, Babinet C, Yaniv M, Barra J Essential role for the homeoprotein vHNF1/HNF1 beta in visceral endoderm differentiation. Development 1999, 126:4785-4794.
46. Kolatsi-Joannou M, et al. Hepatocyte nuclear factor-1 beta: a new kindred with renal cysts and diabetes and gene expression in normal human development. J Am Soc Nephrol 2001, 12:2175-2180.
47. Bellanne-Chantelot C, et al. Clinical spectrum associated with hepatocyte nuclear factor-1 beta mutations. Ann Intern Med 2004, 140:510-517.
48. Bellanne-Chantelot C, et al. Large genomic rearrangements in the hepatocyte nuclear factor-1 beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5. Diabetes 2005, 54:3126-3132.
49. Edghill EL, Bingham C, Ellard S, Hattersley AT Mutations in hepatocyte nuclear factor-1 beta and their related phenotypes. J Med Genet 2006, 43:84-90.
50. Ulinski T, et al. Renal phenotypes related to hepatocyte nuclear factor-1 beta (TCF2) mutations in a pediatric cohort. J Am Soc Nephrol 2006, 17:497-503.
51. Lindner TH, et al. A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1 beta. Hum Mol Genet 1999, 8:2001-2008.
52. Bingham C, et al. Mutations in the hepatocyte nuclear factor-1 beta gene are associated with familial hypoplastic glomerulocystic kidney disease. Am J Hum Genet 2001, 68:219-224.
53. Bingham C, et al. Solitary functioning kidney and diverse genital tract malformations associated with hepatocyte nuclear factor-1 beta mutations. Kidney Int 2002, 61:1243-1251.
54. Rizzoni G, et al. Familial hypoplastic glomerulocystic kidney. A new entity?. Clin Nephrol 1982, 18:263-268.
55. Decramer S, et al. Anomalies of the TCF2 gene are the main cause of fetal bilateral hyperechogenic kidneys. J Am Soc Nephrol 2007.
56. Rebouissou S, et al. Germline hepatocyte nuclear factor 1 alpha and 1 beta mutations in renal cell carcinomas. Hum Mol Genet 2005, 14:603-614.
57. Kallmann FJ, Schoenfeld WA, Barrera SE The genetic aspects of primary eunuchoidism. Am J Ment Defic 1944, 48:303-336.
58. De Morsier G Median craioencephalic dysraphias and olfactogenital dysplasia. World Neurol 1962, 3:485-506.
59. Tsai PS, Gill JC Mechanisms of disease: Insights into X-linked and autosomal-dominant Kallmann syndrome. Nat Clin Pract Endocrinol Metab 2006, 2:160-171.
60. Naftolin F, Harris GW, Bobrow M Effect of purified luteinizing hormone releasing factor on normal and hypogonadotrophic anosmic men. Nature 1971, 232:496-497.
61. Schwanzel-Fukuda M, Bick D, Pfaff DWL Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome. Brain Res Mol Brain Res 1989, 6:311-326.
62. Dode C, et al. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet 2003, 33:463-465.
63. Dode C, et al. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genet 2006, 2:e175.
64. Dode C, et al. Novel FGFR1 sequence variants in Kallmann syndrome, and genetic evidence that the FGFR1c isoform is required in olfactory bulb and palate morphogenesis. Hum Mutat 2007, 28:97-98.
65. Townes PL, Brocks ER Hereditary syndrome of imperforate anus with hand, foot, and ear anomalies. J Pediatr 1972, 81:321-326.
66. O'Callaghan M, Young ID The Townes-Brocks syndrome. J Med Genet 1990, 27:457-461.
67. Kurnit DM, Steele MW, Pinsky L, Dibbins A Autosomal dominant transmission of a syndrome of anal, ear, renal, and radial congenital malformations. J Pediatr 1978, 93:270-273.
68. Allanson JE, Hunter AG, Mettler GS, Jimenez C Renal tubular dysgenesis: a not uncommon autosomal recessive syndrome: a review. Am J Med Genet 1992, 43:811-814.
69. McFadden DE, Pantzar JT, Van Allen MI, Langlois S Renal tubular dysgenesis with calvarial hypoplasia: report of two additional cases and review. J Med Genet 1997, 34:846-848.
70. Kumar D, Moss G, Primhak R, Coombs R Congenital renal tubular dysplasia and skull ossification defects similar to teratogenic effects of angiotensin converting enzyme (ACE) inhibitors. J Med Genet 1997, 34:541-555.
71. Mahieu-Caputo D, et al. Twin-to-twin transfusion syndrome. Role of the fetal renin-angiotensin system. Am J Pathol 2000, 156:629-636.
72. Barr M, Cohen MM ACE inhibitor fetopathy and hypocalvaria: the kidney-skull connection. Teratology 1991, 44:485-495.
73. Gribouval O, et al. Mutations in genes in the renin-angiotensin system are associated with autosomal recessive renal tubular dysgenesis. Nat Genet 2005, 37:964-968.
74. Bueva A, Guignard JP Renal function in preterm neonates. Pediatr Res 1994, 36:572-577.
75. Krzemien G, Roszkowska-Blaim M, Kostro I, et al. Urological anomolies in children with renal agenesis of multicystic dysplastic kidney. J Appl Genet 2006, 46:171.
76. Shibata S, Nagata M Pathogenesis of human renal dysplasia: an alternative scenario to the major theories. Pediatr Int 2003, 45:605-609.
77. Kuwertz-Broeking E, Brinkmann OA, Von Lengerke HJ, et al. Unilateral multicystic dysplastic kidney experience in children. BJU Int 2004, 93:388.
78. D'Alberton A, Reschini E, Ferrari N, Candiani P Prevalence of urinary tract abnormalities in a large series of patients with utero-vaginal atresia. J Urol 1981, 126:623-624.
79. Fedele L, Bianchi S, Agnoli B, Tozzi L, Vignali M Urinary tract anomalies associated with unicornuate uterus. J Urol 1996, 155:847-848.
80. Raj GV, Auge BK, Assimos D, Preminger GM Metabolic abnormalities associated with renal calculi in patients with horseshoe kidneys. J Endourol 2004, 18:157-161.
81. Oda T, et al. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nature Genet 1997, 16:235-242.
82. Wilkie AOM, et al. Apert syndrome results from localised mutations of FGFR2 and is allelic with Crouzon syndrome. Nature Genet 1996, 9:165-172.
83. Hatada I, et al. An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome. Nat Genet 1996, 14:171-173.
84. Wagner T, et al. Autosomal sex reversal and compomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 1994, 79:1111-1120.
85. Houston CS, et al. The Campomelic syndrome: review, report of 17 cases and follow-up on the currently 17-year-old boy first reported by Maroteaux et al in 1971. Am J Med Genet 1998, 15:3-28.
86. Sakaki-Yumoto M, et al. The murine homolog of SALL4, a causative gene in Okihiro syndrome, is essential for embryonic stem cell proliferation, and cooperates with Sall1 in anorectal, heart, brain and kidney development. Development 2006, 133:3005-3013.
87. McGregor L, et al. Fraser syndrome and mouse blebbed phenotype caused by mutations in FRAS1/Fras1 encoding a putative extracellular matrix protein. Nat Genet 2003, 34:203-208.
88. Van Esch H, et al. GATA3 haplo-insufficiency causes human HDR syndrome. Nature 2000, 406:419-422.
89. Franco B, et al. A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature 1991, 353:529-536.
90. Bamshad M, et al. Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome. Nat Genet 1997, 16:311-315.
91. Bohn S, et al. Distinct molecular and morphogenetic properties of mutations in the human HNF1 beta gene that lead to defective kidney development. J Am Soc Nephrol 2003, 14:2033-2041.
92. Pilia G, et al. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nature Genet 1996, 12:241-247.
93. Tint GS, et al. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz Syndrome. N Engl J Med 1994, 330:107-113.
94. Preuss N, et al. PEX1 mutations in complementation group 1 of Zellweger spectrum patients correlate with severity of disease. Pediatr Res 2002, 51:706-714.